AIM
AZN icon

Aigen Investment Management’s AstraZeneca AZN Stock Holding History

Aigen Investment Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,485
Closed -$490K – 544
2026
Q1 		$490K Buy
+2,485
New +$479K 0.13% 214
2025
Q3 		– Sell
-12,384
Closed -$1.73M – 791
2025
Q2 		$1.73M Buy
12,384
+9,853
+389% +$1.38M 0.24% 121
2025
Q1 		$372K Sell
2,531
-809
-24% -$117K 0.06% 428
2024
Q4 		$438K Buy
3,340
+1,365
+69% +$191K 0.08% 368
2024
Q3 		$308K Buy
+1,975
New +$319K 0.06% 463
2022
Q1 		– Sell
-11,223
Closed -$1.26M – 568
2021
Q4 		$1.26M Buy
+11,223
New +$1.32M 0.08% 343
2021
Q2 		– Sell
-32,597
Closed -$3.24M – 469
2021
Q1 		$3.24M Buy
32,597
+16,309
+100% +$1.64M 0.43% 61
2020
Q4 		$1.63M Buy
+16,288
New +$1.73M 0.21% 118

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Aigen Investment Management's AZN Position: Q2 2026 in Review

Aigen Investment Management sold out of AstraZeneca (AZN) in Q2 2026, closing a stake of 2,485 shares — an estimated $490K sold.

Aigen Investment Management first reported a position in AZN in Q4 2020 and held it in 8 quarters. The position peaked at $3.24M in Q1 2021. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Aigen Investment Management reported no remaining AstraZeneca position as of Q2 2026 after selling out during the quarter.
  • Aigen Investment Management sold 2,485 AstraZeneca shares in Q2 2026, an estimated $490K.
  • Aigen Investment Management first reported a position in AstraZeneca in Q4 2020 and held it in 8 quarters.
  • Aigen Investment Management's AstraZeneca position peaked at $3.24M in Q1 2021.
  • 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Aigen Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.